Technical Analysis for CODX - Co-Diagnostics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Flat |
Historical CODX trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Spinning Top | Other | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Inside Day | Range Contraction | 2.18% | |
Wide Bands | Range Expansion | 2.18% | |
New 52 Week Closing Low | Bearish | 8.67% | |
Wide Bands | Range Expansion | 8.67% | |
Down 3 Days in a Row | Weakness | 8.67% | |
Down 4 Days in a Row | Weakness | 8.67% | |
Down 5 Days in a Row | Weakness | 8.67% | |
Outside Day | Range Expansion | 1.14% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Rose Above 10 DMA | about 17 hours ago |
Up 3% | about 17 hours ago |
10 DMA Resistance | about 18 hours ago |
Up 2% | about 18 hours ago |
60 Minute Opening Range Breakout | about 18 hours ago |
Get a Trading Sidekick!
- Earnings date: 05/12/2021
Co-Diagnostics, Inc. Description
Co-Diagnostics, Inc. is a molecular diagnostics company. The Company is engaged in developing, manufacturing and marketing diagnostics technology. Its reagents are used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, such as deoxyribonucleic acid and ribonucleic acid. It also sells diagnostic equipment from other manufacturers as self-contained lab systems (MDx device). The Company uses its proprietary test design system and proprietary reagents to design and sell polymerase chain reaction diagnostic tests for diseases and pathogens starting with tests for tuberculosis, a drug resistant tuberculosis test, hepatitis B and C, Malaria, dengue, human immunodeficiency virus and Zika virus, all of which tests have been designed and validated in its laboratory. Its diagnostics systems enable molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Biotechnology Clinical Medicine Diseases Acid Hepatitis B Medical Tests Diagnostic Tests Genetic Disease Molecular Diagnostics Genetic Diseases Immunodeficiency Organisms Polymerase Chain Reaction Malaria Ortho Clinical Diagnostics Diagnostic Equipment Tuberculosis Mdx Zika Dengue
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 30.99 |
52 Week Low | 7.86 |
Average Volume | 1,272,092 |
200-Day Moving Average | 13.80 |
50-Day Moving Average | 12.46 |
20-Day Moving Average | 9.22 |
10-Day Moving Average | 8.92 |
Average True Range | 0.85 |
ADX | 26.28 |
+DI | 19.13 |
-DI | 30.05 |
Chandelier Exit (Long, 3 ATRs ) | 12.11 |
Chandelier Exit (Short, 3 ATRs ) | 10.41 |
Upper Bollinger Band | 10.77 |
Lower Bollinger Band | 7.67 |
Percent B (%b) | 0.4 |
BandWidth | 33.60 |
MACD Line | -1.00 |
MACD Signal Line | -1.10 |
MACD Histogram | 0.1001 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 9.76 | ||||
Resistance 3 (R3) | 9.73 | 9.42 | 9.61 | ||
Resistance 2 (R2) | 9.42 | 9.20 | 9.43 | 9.56 | |
Resistance 1 (R1) | 9.16 | 9.07 | 9.29 | 9.19 | 9.52 |
Pivot Point | 8.85 | 8.85 | 8.92 | 8.86 | 8.85 |
Support 1 (S1) | 8.59 | 8.63 | 8.72 | 8.62 | 8.28 |
Support 2 (S2) | 8.28 | 8.50 | 8.29 | 8.24 | |
Support 3 (S3) | 8.02 | 8.28 | 8.19 | ||
Support 4 (S4) | 8.05 |